Yemen | News | Schistosomiasis programme in Yemen to restart, 3 May 2012

Schistosomiasis programme in Yemen to restart, 3 May 2012

Print PDF

3 May 2012 – Following a nine month hiatus caused by the civil and political unrest in the country, the schistosomiasis programme’s main funders, the World Bank, have agreed to reinstatement of funding for the six-year national programme.

Yemen suffers from a high disease burden of schistosomiasis (bilharzia). It has extensive reported cases of schistosomiasis and intestinal worms, with three million people estimated to be infected and 600 000 severe chronic cases.

A six-year nationwide schistosomiasis and intestinal worms programme started in 2010 with the aim of eliminating schistosomiasis-related morbidity through annual treatment. The programme is run by the Ministry of Public Health and Population and involves a collaborative partnership with the World Bank, World Health Organization and the Schistosomiasis Control Initiative.  

The first treatment round took place in in December 2010 and April 2011. Around 4 million people were treated and 87% of school age-children targeted were reached. This exceeded both the programme target and the WHO target of 75% coverage. Crucially, this number included enrolled and non-enrolled children.

A treatment campaign that was originally planned for prior to the suspension will now be carried out in May 2012. This campaign is expected to deliver treatment to 2 300 000 people around the country, even in security-compromised areas.

Key health-related statistics

Total population (000s) 27 426
Total health expenditure (% of general government expenditure) 3.9
Primary health care units and centres (per 10 000 population) 1.6
Life expectancy 65.3

Source: Framework for health information systems and core indicators for monitoring health situation and health system performance, 2018

See Yemen country profile

Regional Health Observatory

Contact us

WHO Representative
PO Box 543
Sana'a